CLC Number:
| [1] 王铁军,耿慧,祝永刚,等.乳腺癌化疗现状及相关研究进展[J].现代生物医学进展,2013,13(22): 4398-4400. [2] 徐方贵,吴德柱,王剑平,等.紫杉类化疗方案治疗乳腺癌继发糖尿病的相关分析[J].现代肿瘤医学,2014,22(5): 1094-1096. [3] 朱先明,钟志军.影响乳腺癌患者术后复发转移的因素分析[J].中国实用医药,2010,5 (6): 86-87. [4] 倪志强,方艳秋,刘多,等.DC-CIK联合化疗对乳腺癌患者免疫功能、无进展生存期及生活质量的影响[J].中国妇幼保健,2013,28: 5134-5137. [5] 黄晓红,智生芳,毕伟.乳腺癌术后化疗对骨质密度的影响[J].中国肿瘤临床与康复,2014,21(3): 355-357. [6] 刘秋明,曹亚丽,吴晓波,等.乳腺癌分子分型在多西他赛密集新辅助化疗疗效及预后中的预测价值[J].肿瘤防治研究,2013,40(1): 59-64. [7] 杨胜利,杨劼,叶国麟,等. FUDR与5-Fu在乳腺癌新辅助化疗中的临床观察[J].中国肿瘤临床与康复,2012,19(1): 73-74. [8] 莫春连,卢永刚.乳腺癌治疗进展[J].山西医药杂志,2010,39(9): 843-844. |
| [1] | ZHANG Peipei, LIU Dequan, WANG Bei, HE Shuqian, LI Fei, DING Hongyu, SUN Hongjun. Sonographic findings and pathological features of non-mass pure ductal carcinoma in situ [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 54-58. |
| [2] | . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 130-132. |
| [3] | MENG Fanchao, FENG Lu, SHAO Guangrui. FOXM1 regulates transcription of SYK in breast cancer cell line MCF-7 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 19-24. |
| [4] | LIN Jiaxiang, GUO Zijia, SU Peng, WANG Xiao, GUO Yaxin, WU Xiaojuan, XIANG Lei, ZHOU Zhiqiang, WANG Yan, CUI Xiujie, PAN Aifeng, GUO Chenghao. The role of CIP2A in the transformation of breast ductal epithelium and prognosis of invasive breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 100-106. |
| [5] | XU Zhihong, LIU Rongfeng, WANG Xiaoxiang, FENG Li, YAO Tiezhu, LIU Hong. Efficacy and safety of Yangzheng Xiaoji capsule combined with chemotherapy in treating metastatic breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(5): 79-83. |
| [6] | LI Ranran, ZHANG Pengfei, YUAN Bing, FANG Feifei, HAN Mingyong. Breast tumor deriving VEGF induces vascular endothelial cells to suppress immune functions [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 38-43. |
| [7] | . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(S2): 43-44. |
| [8] | LI Ling, WANG Lili, WANG Shengjiang, YU Chao, LIU Yanpeng, XU Chengwei. Research on the relationship between plasma D-dimer level and prognosis of breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(9): 77-80. |
| [9] | SUN Ying, YU Jing, WEI Junmin, FAN Cong, WANG Xiuwen, GAO Peng, JIANG Liyu, MA Tingting. Clinical and pathological characteristics of breast carcinoma in women aged 35 years or younger [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(7): 71-74. |
| [10] | . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(5): 109-110. |
| [11] | MA Zhen-shen1, WANG Da-wei2, SUN Xiu-bin3, SHI Hao1, PANG Tao1, DONG Gui-qing1, ZHANG Cheng-qi1. Quantitative analysis of 3.0T MR in differential diagnosis of breast lesions [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(9): 79-83. |
| [12] | CHI Wei-wei1, GAO Hai-yan2, GAO Hai-dong3. The molecular mechanism of transforming growth factor-β1-induced transmembrane protein participating in the development of breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(4): 26-29. |
| [13] | LI Shan-shan， SUN Ying, DING Huan, LI Li. β-catenin expressions in different subtypes of breast cancer and its clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 107-110. |
| [14] |
CEN Dong-zhi.
Overexpression of NRIP3 gene inhibited metastasis in lymph node negative breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 83-. |
| [15] |
WANG Jing-nan1， ZHENG Yan2， XIAO Dong-jie2， LI Jin-xing1， DING Bu-tong2， LIU Xiang-dong3， WANG Yun-shan2,4.
Correlation between SATB1 and HER2 expressions and the tumor grade in breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 91-. |
|
||
